Article
Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Oct 2010
Addad Faouzi, Elalamy Ismail, Chakroun Tahar, Abderrazek Fatma, Dridi Zohra, Hamdi Sonia, Hassine Mohssen, Ben-Farhat Mohamed, Gerotziafas Grigoris, Hatmi Mohamed, Gamra Habib
Abstract excerpt
Platelet glycoprotein IIb/IIIa is a membrane receptor which plays a key role in coronary artery disease and thrombotic events. However, there is a considerable controversy regarding the clinical impact of glycoprotein IIIa platelet antigen 1 (PlA1)/platelet antigen 2 (PlA2) polymorphism as a risk factor for myocardial infarction. To evaluate the association between glycoprotein IIIa PlA1/PlA2 polymorphism and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
